Workflow
汇添富成长焦点混合
icon
Search documents
泛亚微透股价涨5.08%,汇添富基金旗下1只基金位居十大流通股东,持有132.73万股浮盈赚取615.88万元
Xin Lang Cai Jing· 2026-02-06 05:44
从泛亚微透十大流通股东角度 数据显示,汇添富基金旗下1只基金位居泛亚微透十大流通股东。汇添富成长焦点混合(519068)三季 度增持11.77万股,持有股数132.73万股,占流通股的比例为1.46%。根据测算,今日浮盈赚取约615.88 万元。 汇添富成长焦点混合(519068)成立日期2007年3月12日,最新规模33.12亿。今年以来收益3.99%,同 类排名3951/8873;近一年收益30.89%,同类排名3745/8123;成立以来收益392.19%。 2月6日,泛亚微透涨5.08%,截至发稿,报96.03元/股,成交1.57亿元,换手率1.87%,总市值87.39亿 元。 汇添富成长焦点混合(519068)基金经理为陈潇扬。 截至发稿,陈潇扬累计任职时间4年39天,现任基金资产总规模33.12亿元,任职期间最佳基金回 报-25.2%, 任职期间最差基金回报-25.2%。 从基金十大重仓股角度 数据显示,汇添富基金旗下1只基金重仓泛亚微透。汇添富成长焦点混合(519068)四季度减持32.78万 股,持有股数99.95万股,占基金净值比例为2.64%,位居第七大重仓股。根据测算,今日浮盈赚取约 4 ...
机构风向标 | 卓越新能(688196)2025年三季度已披露前十大机构累计持仓占比79.49%
Xin Lang Cai Jing· 2025-10-31 02:17
Group 1 - The core viewpoint of the news is that Zhuoyue New Energy (688196.SH) has seen a significant increase in institutional investor holdings, with 12 institutions holding a total of 95.5945 million shares, representing 79.66% of the total share capital as of October 30, 2025 [1] - The top ten institutional investors collectively hold 79.49% of the shares, with an increase of 1.24 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, four funds increased their holdings, accounting for a 0.68% increase, while three funds decreased their holdings, resulting in a 0.23% decrease [2] - One new public fund was disclosed during this period, while 124 funds were not disclosed compared to the previous quarter [2]
麦澜德股价跌5.02%,汇添富基金旗下1只基金位居十大流通股东,持有36.38万股浮亏损失80.04万元
Xin Lang Cai Jing· 2025-10-17 02:45
Group 1 - The core point of the article highlights the recent decline in the stock price of Mylande, which fell by 5.02% to 41.63 CNY per share, with a trading volume of 63.59 million CNY and a turnover rate of 4.08%, resulting in a total market capitalization of 4.163 billion CNY [1] - Mylande Medical Technology Co., Ltd. specializes in the research, development, production, sales, and services related to pelvic floor and postpartum rehabilitation products, with its main business revenue composition being 36.98% from pelvic rehabilitation products, 33.10% from reproductive rehabilitation products, 24.32% from consumables and accessories, 2.77% from sports rehabilitation products, and 2.18% from other supplementary products [1] Group 2 - Among Mylande's top ten circulating shareholders, a fund under Huatai PineBridge holds a position, having reduced its holdings by 29.94 thousand shares in the second quarter, now holding 36.38 thousand shares, which accounts for 0.99% of the circulating shares [2] - The Huatai Growth Focus Mixed Fund (519068) has a total asset size of 2.851 billion CNY and has achieved a year-to-date return of 18.61%, ranking 4578 out of 8160 in its category, with a one-year return of 15.36%, ranking 5161 out of 8021 [2]